Treatment with S63845 (MCL-1 inhibitor) or A1331852 (BCL-XL inhibitor) reduced viability and induced apoptosis in a subset of neuroblastoma cell lines, due to the release of pro-apoptotic proteins from BCL-XL- or MCL-1-mediated sequestration [92]. Here, MCL1 is linked to neuroblastoma.